首页 > 最新文献

Paediatric Respiratory Reviews最新文献

英文 中文
Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis. 高效调节剂疗法对囊性纤维化患者胃肠道症状和特征的影响。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-20 DOI: 10.1016/j.prrv.2024.07.004
Martina Cecchetti, Luca Scarallo, Paolo Lionetti, Chee Y Ooi, Vito Terlizzi

Highly effective modulator therapy (HEMT), particularly the triple combination elexacaftor-tezacaftor-ivacaftor (ETI), significantly improved clinical outcomes and quality of life in people with Cystic Fibrosis (pwCF). This review analyzes current knowledge on the impact of HEMTs on gastrointestinal (GI) symptoms and features in pwCF. A descriptive review of English literature until February 29, 2024, was conducted using medical databases. Observational studies and clinical trials addressing GI reflux disease (GERD), lower GI symptoms and pancreatic disease were considered. Studies report positive effects of HEMTs on pH levels and bicarbonate secretion as well as improvement on intestinal inflammation. HEMTs also demonstrated positive effects on GERD and lower GI symptoms or conditions CF related such as dysbiosis. Taking ETI during pregnancy could also allow resolution of meconium ileus in fetuses with CF. The best benefits were observed in pancreatic function, potentially delaying CF-related diabetes and recovering pancreatic function in some children on ETI. Larger trials, particularly in pediatric populations, need to confirm these findings and explore long-term effects.

高效调节剂疗法(HEMT),尤其是 elexacaftor-tezacaftor-ivacaftor 三联疗法(ETI),可显著改善囊性纤维化患者(pwCF)的临床疗效和生活质量。本综述分析了目前关于 HEMTs 对囊性纤维化患者胃肠道症状和特征的影响的知识。我们使用医学数据库对截至 2024 年 2 月 29 日的英文文献进行了描述性综述。研究考虑了针对消化道反流病(GERD)、下消化道症状和胰腺疾病的观察性研究和临床试验。研究报告显示,HEMTs 对 pH 值和碳酸氢盐分泌有积极影响,并能改善肠道炎症。HEMTs 还对胃食管反流病和下消化道症状或与 CF 有关的疾病(如菌群失调)有积极作用。怀孕期间服用 ETI 还能缓解 CF 胎儿的胎粪回肠症。在胰腺功能方面观察到的最佳益处是,服用 ETI 有可能延缓与 CF 相关的糖尿病,并恢复一些儿童的胰腺功能。需要进行更大规模的试验,特别是在儿科人群中进行试验,以证实这些发现并探索其长期效果。
{"title":"Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis.","authors":"Martina Cecchetti, Luca Scarallo, Paolo Lionetti, Chee Y Ooi, Vito Terlizzi","doi":"10.1016/j.prrv.2024.07.004","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.07.004","url":null,"abstract":"<p><p>Highly effective modulator therapy (HEMT), particularly the triple combination elexacaftor-tezacaftor-ivacaftor (ETI), significantly improved clinical outcomes and quality of life in people with Cystic Fibrosis (pwCF). This review analyzes current knowledge on the impact of HEMTs on gastrointestinal (GI) symptoms and features in pwCF. A descriptive review of English literature until February 29, 2024, was conducted using medical databases. Observational studies and clinical trials addressing GI reflux disease (GERD), lower GI symptoms and pancreatic disease were considered. Studies report positive effects of HEMTs on pH levels and bicarbonate secretion as well as improvement on intestinal inflammation. HEMTs also demonstrated positive effects on GERD and lower GI symptoms or conditions CF related such as dysbiosis. Taking ETI during pregnancy could also allow resolution of meconium ileus in fetuses with CF. The best benefits were observed in pancreatic function, potentially delaying CF-related diabetes and recovering pancreatic function in some children on ETI. Larger trials, particularly in pediatric populations, need to confirm these findings and explore long-term effects.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Face masks and protection against COVID-19 and other viral respiratory infections: Assessment of benefits and harms in children. 口罩与预防 COVID-19 和其他病毒性呼吸道感染:儿童受益与危害评估。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-06 DOI: 10.1016/j.prrv.2024.08.003
Johanna Sandlund, Ram Duriseti, Shamez N Ladhani, Kelly Stuart, Jeanne Noble, Tracy Beth Høeg

Mask mandates for children were implemented at schools and childcare centers during the COVID-19 pandemic, and the US continues to recommend masking down to the age of two in certain settings. Medical interventions should be informed by high-quality evidence and consider the possibility of harm (i.e., include harm-benefit analyses). In this review, we weigh the existing evidence for the effectiveness of mask mandates to protect against COVID-19 and other viral respiratory infections and the harms associated with face mask wearing in children. There is a lack of robust evidence of benefit from masking children to reduce transmission of SARS-CoV-2 or other respiratory viruses. The highest quality evidence available for masking children for COVID-19 or other viral respiratory infections has failed to find a beneficial impact against transmission. Mechanistic studies showing reduced viral transmission from use of face masks and respirators have not translated to real world effectiveness. Identified harms of masking include negative effects on communication and components of speech and language, ability to learn and comprehend, emotional and trust development, physical discomfort, and reduction in time and intensity of exercise. Effectiveness of child masking has not been demonstrated, while documented harms of masking in children are diverse and non-negligible and should prompt careful reflection. Recommendations for masking children fail basic harm-benefit analyses.

在 COVID-19 大流行期间,学校和托儿所强制要求儿童佩戴口罩,美国继续建议在某些情况下两岁以下儿童佩戴口罩。医疗干预措施应以高质量的证据为依据,并考虑危害的可能性(即包括危害-效益分析)。在本综述中,我们权衡了现有证据,以确定强制佩戴口罩对预防 COVID-19 和其他病毒性呼吸道感染的有效性,以及儿童佩戴口罩的相关危害。目前缺乏有力的证据证明儿童戴口罩可减少 SARS-CoV-2 或其他呼吸道病毒的传播。关于儿童戴口罩治疗 COVID-19 或其他呼吸道病毒感染,现有的最高质量的证据也没有发现对减少传播有益的影响。机理研究显示,使用口罩和呼吸器可减少病毒传播,但这些研究并未转化为实际效果。已确定的戴口罩的危害包括对交流和言语表达能力、学习和理解能力、情感和信任发展、身体不适以及运动时间和强度的减少产生负面影响。儿童掩蔽的有效性尚未得到证实,而记录在案的儿童掩蔽危害多种多样,不可忽视,应引起认真反思。对儿童进行掩蔽的建议未能通过基本的危害-效益分析。
{"title":"Face masks and protection against COVID-19 and other viral respiratory infections: Assessment of benefits and harms in children.","authors":"Johanna Sandlund, Ram Duriseti, Shamez N Ladhani, Kelly Stuart, Jeanne Noble, Tracy Beth Høeg","doi":"10.1016/j.prrv.2024.08.003","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.08.003","url":null,"abstract":"<p><p>Mask mandates for children were implemented at schools and childcare centers during the COVID-19 pandemic, and the US continues to recommend masking down to the age of two in certain settings. Medical interventions should be informed by high-quality evidence and consider the possibility of harm (i.e., include harm-benefit analyses). In this review, we weigh the existing evidence for the effectiveness of mask mandates to protect against COVID-19 and other viral respiratory infections and the harms associated with face mask wearing in children. There is a lack of robust evidence of benefit from masking children to reduce transmission of SARS-CoV-2 or other respiratory viruses. The highest quality evidence available for masking children for COVID-19 or other viral respiratory infections has failed to find a beneficial impact against transmission. Mechanistic studies showing reduced viral transmission from use of face masks and respirators have not translated to real world effectiveness. Identified harms of masking include negative effects on communication and components of speech and language, ability to learn and comprehend, emotional and trust development, physical discomfort, and reduction in time and intensity of exercise. Effectiveness of child masking has not been demonstrated, while documented harms of masking in children are diverse and non-negligible and should prompt careful reflection. Recommendations for masking children fail basic harm-benefit analyses.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory infections in low and middle-income countries. 中低收入国家的呼吸道感染。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-02 DOI: 10.1016/j.prrv.2024.08.002
Lisa Frigati, Leonore Greybe, Savvas Andronikou, Ernst Eber, Shyam Sunder B Venkatakrishna, Pierre Goussard

Objectives: To investigate the epidemiology, aetiology, diagnostics and management of childhood pneumonia in low and middle income countries (LMICs).

Design: Review of published english literature from 2019 to February 2024.

Results: Lower respiratory tract infections (LRTIs) still result in significant mortality in children under 5 years of age in LMICs. Important studies have reported a change in the pathogenesis of LRTIs over the last 5 years with respiratory syncytial virus (RSV) resulting in a large burden of disease. SARS-CoV-2 had a significant direct and indirect impact in children in LMICs. Mycobacterium tuberculosis (MTB) remains a priority pathogen in all children. Nucleic acid amplification and rapid antigen tests have improved diagnostic accuracy for MTB and other bacterial pathogens. Point of care diagnostics may overcome some limitations, but there is a need for better cost-effective diagnostics. Access to shorter courses of TB treatment are now recommended for some children, but child friendly formulations are lacking. The role of chest X-ray in TB has been recognized and included in guidelines, and lung ultrasound to diagnose LRTI is showing promise as a lower cost and accessible option.

Conclusion: Advances in diagnostics and large multi-centre studies have provided increased understanding of the causative pathogens of LRTIs in LMICs. Increased access to preventive strategies such as vaccines, treatment modalities including antivirals, and addressing upstream factors such as poverty are essential if further declines in LRTIs in LMICs are to be realised.

目的:调查中低收入国家(LMIC)儿童肺炎的流行病学、病因学、诊断和管理:调查中低收入国家(LMICs)儿童肺炎的流行病学、病因、诊断和管理:回顾 2019 年至 2024 年 2 月发表的英文文献:在中低收入国家,下呼吸道感染(LRTIs)仍然是导致 5 岁以下儿童死亡的重要原因。有重要研究报告称,在过去五年中,下呼吸道感染的发病机制发生了变化,呼吸道合胞病毒(RSV)造成了巨大的疾病负担。SARS-CoV-2 对低收入国家的儿童产生了重大的直接和间接影响。结核分枝杆菌(MTB)仍然是所有儿童的重点病原体。核酸扩增和快速抗原检测提高了对结核分枝杆菌和其他细菌病原体的诊断准确性。护理点诊断法可以克服某些局限性,但仍需要成本效益更好的诊断方法。现在建议一些儿童接受疗程更短的结核病治疗,但缺乏适合儿童的配方。胸部 X 光检查在结核病中的作用已得到认可并被纳入指南,而肺部超声波诊断 LRTI 作为一种成本较低、易于获得的选择也显示出了前景:诊断学的进步和大型多中心研究使人们对低收入和中等收入国家 LRTI 的致病病原体有了更多的了解。如果要实现低收入和中等收入国家 LRTI 发病率的进一步下降,就必须增加疫苗等预防策略和包括抗病毒药物在内的治疗方法的普及率,并解决贫困等上游因素。
{"title":"Respiratory infections in low and middle-income countries.","authors":"Lisa Frigati, Leonore Greybe, Savvas Andronikou, Ernst Eber, Shyam Sunder B Venkatakrishna, Pierre Goussard","doi":"10.1016/j.prrv.2024.08.002","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.08.002","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the epidemiology, aetiology, diagnostics and management of childhood pneumonia in low and middle income countries (LMICs).</p><p><strong>Design: </strong>Review of published english literature from 2019 to February 2024.</p><p><strong>Results: </strong>Lower respiratory tract infections (LRTIs) still result in significant mortality in children under 5 years of age in LMICs. Important studies have reported a change in the pathogenesis of LRTIs over the last 5 years with respiratory syncytial virus (RSV) resulting in a large burden of disease. SARS-CoV-2 had a significant direct and indirect impact in children in LMICs. Mycobacterium tuberculosis (MTB) remains a priority pathogen in all children. Nucleic acid amplification and rapid antigen tests have improved diagnostic accuracy for MTB and other bacterial pathogens. Point of care diagnostics may overcome some limitations, but there is a need for better cost-effective diagnostics. Access to shorter courses of TB treatment are now recommended for some children, but child friendly formulations are lacking. The role of chest X-ray in TB has been recognized and included in guidelines, and lung ultrasound to diagnose LRTI is showing promise as a lower cost and accessible option.</p><p><strong>Conclusion: </strong>Advances in diagnostics and large multi-centre studies have provided increased understanding of the causative pathogens of LRTIs in LMICs. Increased access to preventive strategies such as vaccines, treatment modalities including antivirals, and addressing upstream factors such as poverty are essential if further declines in LRTIs in LMICs are to be realised.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The wheezy infant: A viewpoint from low-middle income countries 喘息的婴儿:来自中低收入国家的观点。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2022.06.001

Objective

To review the recent evidence in the literature of various aspects of recurrent/severe wheezing in children under 3 in low-middle income countries [LMICS].

Sources

A non-systematic review including articles in English. We mainly selected publications from the last 5 years. Studies on epidemiology, aetiology, diagnosis, treatment, and prevention were included in the search. We reviewed differential diagnoses of wheezing that focused on LMICS. We also reviewed aspects of prevention.

Summary of the findings

Many epidemiological studies have shown a variable but significant number of wheezy infants [WI] cases in LMICS when compared to other countries.

The differential diagnosis of causes of wheezing in this age group is mandatory, taking into account local facilities.

Few treatment options have been well studied for this age group. In LMICS, a pragmatic approach could be considered, as described in the article.

It is difficult to study primary prevention for WI and secondary prevention (mainly environmental) may have some impact.

A schematic approach for recurrent wheezers is presented, which takes into account settings with limited resources.

Conclusion

Severely or recurrently wheezy children under 3 is a common clinical issue in LMICS. Studies on this age group are needed to reduce the significant morbidity. It may be possible to lower the high burden of wheezing in this age group by selecting the phenotype which may respond to inhaled steroids.

目的回顾中低收入国家(LMICS)3 岁以下儿童反复/严重喘息各方面的最新文献证据:资料来源:非系统性综述,包括英文文章。我们主要选择了过去 5 年中的出版物。检索包括有关流行病学、病因学、诊断、治疗和预防的研究。我们回顾了以 LMICS 为重点的喘息的鉴别诊断。我们还审查了预防的各个方面:许多流行病学研究表明,与其他国家相比,低收入国家的喘息婴儿 [WI] 病例数量不一,但数量可观。考虑到当地的设施,必须对这一年龄组的喘息病因进行鉴别诊断。针对这一年龄组的治疗方案鲜有研究。在低收入国家,可以考虑文章中所述的务实方法。很难研究 WI 的一级预防,二级预防(主要是环境)可能会有一些影响。文章介绍了针对反复喘息者的示意性方法,其中考虑到了资源有限的环境:结论:3 岁以下儿童喘息严重或反复发作是低收入国家常见的临床问题。需要对这一年龄组的儿童进行研究,以降低重大的发病率。通过选择可能对吸入类固醇有反应的表型,有可能降低这一年龄组的高喘息负担。
{"title":"The wheezy infant: A viewpoint from low-middle income countries","authors":"","doi":"10.1016/j.prrv.2022.06.001","DOIUrl":"10.1016/j.prrv.2022.06.001","url":null,"abstract":"<div><h3>Objective</h3><p>To review the recent evidence in the literature of various aspects of recurrent/severe wheezing in children under 3 in low-middle income countries [LMICS].</p></div><div><h3>Sources</h3><p>A non-systematic review including articles in English. We mainly selected publications from the last 5 years. Studies on epidemiology, aetiology, diagnosis, treatment, and prevention were included in the search. We reviewed differential diagnoses of wheezing that focused on LMICS. We also reviewed aspects of prevention.</p></div><div><h3>Summary of the findings</h3><p>Many epidemiological studies have shown a variable but significant number of wheezy infants [WI] cases in LMICS when compared to other countries.</p><p>The differential diagnosis of causes of wheezing in this age group is mandatory, taking into account local facilities.</p><p>Few treatment options have been well studied for this age group. In LMICS, a pragmatic approach could be considered, as described in the article.</p><p>It is difficult to study primary prevention for WI and secondary prevention (mainly environmental) may have some impact.</p><p>A schematic approach for recurrent wheezers is presented, which takes into account settings with limited resources.</p></div><div><h3>Conclusion</h3><p>Severely or recurrently wheezy children under 3 is a common clinical issue in LMICS. Studies on this age group are needed to reduce the significant morbidity. It may be possible to lower the high burden of wheezing in this age group by selecting the phenotype which may respond to inhaled steroids.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40560748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulse oximetry in patients with pigmented skin: What I should know 色素性皮肤患者的脉搏血氧仪:我应该知道什么
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.06.001

Pulse oximetry is widely used to non-invasively estimate the oxygen saturation of haemoglobin in arterial blood (SpO2). It is used widely throughout healthcare and was used extensively during the Covid-19 pandemic to detect and treat hypoxic patients. Research has suggested that pulse oximetry is less accurate in patients with darker skin. This led the US Food and Drug Administration agency (FDA) to issue a safety statement warning that pulse oximeters may be inaccurate when patients have pigmented skin.

Evidence suggests that the oxygen saturation of arterial blood (SaO2) may be being overestimated by measuring SpO2 in those with pigmented skin. The degree of overestimation increases as SaO2 decreases especially when SpO2 reads below 80%. We review how pulse oximetry works and consider the implications for a patient’s health when interpreting SpO2 in individuals with pigmented skin.

脉搏血氧仪被广泛用于无创估算动脉血中血红蛋白的氧饱和度(SpO2)。脉搏血氧仪被广泛应用于医疗保健领域,并在 Covid-19 大流行期间被广泛用于检测和治疗缺氧患者。研究表明,脉搏血氧仪在皮肤较黑的患者中准确性较低。这导致美国食品和药物管理局 (FDA) 发布了一份安全声明,警告说当患者皮肤有色素沉着时,脉搏血氧仪可能会不准确。高估的程度会随着 SaO2 的降低而增加,尤其是当 SpO2 低于 80% 时。我们回顾了脉搏血氧仪的工作原理,并考虑了在解释色素性皮肤患者的 SpO2 时对患者健康的影响。
{"title":"Pulse oximetry in patients with pigmented skin: What I should know","authors":"","doi":"10.1016/j.prrv.2024.06.001","DOIUrl":"10.1016/j.prrv.2024.06.001","url":null,"abstract":"<div><p><span>Pulse oximetry<span> is widely used to non-invasively estimate the oxygen saturation of haemoglobin in arterial blood (SpO</span></span><sub>2</sub>). It is used widely throughout healthcare and was used extensively during the Covid-19 pandemic to detect and treat hypoxic patients. Research has suggested that pulse oximetry is less accurate in patients with darker skin. This led the US Food and Drug Administration agency (FDA) to issue a safety statement warning that pulse oximeters may be inaccurate when patients have pigmented skin.</p><p>Evidence suggests that the oxygen saturation of arterial blood (SaO<sub>2</sub>) may be being overestimated by measuring SpO<sub>2</sub> in those with pigmented skin. The degree of overestimation increases as SaO<sub>2</sub> decreases especially when SpO<sub>2</sub> reads below 80%. We review how pulse oximetry works and consider the implications for a patient’s health when interpreting SpO<sub>2</sub> in individuals with pigmented skin.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141399961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simulation based education in paediatric resuscitation 儿科复苏模拟教育
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.05.002

There is increasing use of clinical Simulation Based Education (SBE) in healthcare due to an increased focus on patient safety, the call for a new training model not based solely on apprenticeship, a desire for standardised educational opportunities that are available on-demand, and a need to practice and hone skills in a controlled environment. SBE programs should be evaluated against Kirkpatrick level 3 or 4 criteria to ensure they improve patient or staff outcomes in the real world. SBE programs have been shown to improve outcomes in neonatology – reductions in hypoxic ischaemic encephalopathy, in brachial plexus injury, rates of school age cerebral palsy, reductions in 24hr mortality and improvements in first pass intubation rates. In paediatrics SBE programs have shown improvements in paediatric cardiac arrest survival, PICU survival, reduced PICU admissions, reduced PICU length of stay and reduced time to critical operations. SBE can improve the non-technical tasks of teamwork, leadership and communication (within the team and with patients and carers). Simulation is a useful tool in Quality and Safety and is used to identify latent safety issues that can be addressed by future programs. In high stakes assessment simulation can be a mode of assessment, however, care needs to be taken to ensure the tool is validated carefully.

在医疗保健领域,临床模拟教育(SBE)的使用越来越多,这是因为人们越来越重视患者安全,呼吁建立一种新的培训模式,而不仅仅是学徒制,希望有按需提供的标准化教育机会,以及需要在可控环境中练习和磨练技能。应根据 Kirkpatrick 3 级或 4 级标准对 SBE 项目进行评估,以确保它们能在现实世界中改善患者或员工的治疗效果。事实证明,SBE 项目可改善新生儿科的治疗效果--减少缺氧缺血性脑病、臂丛神经损伤、学龄期脑瘫发生率、降低 24 小时死亡率并提高首次插管率。在儿科领域,SBE 计划提高了儿科心脏骤停患者的存活率、重症监护病房的存活率,减少了重症监护病房的入院人数,缩短了重症监护病房的住院时间,缩短了重症手术的时间。SBE 可以改善团队合作、领导力和沟通(团队内部以及与患者和护理人员)等非技术性任务。模拟是质量与安全方面的一个有用工具,可用于发现潜在的安全问题,并在今后的计划中加以解决。在高风险评估中,模拟可以作为一种评估模式,但需要注意确保该工具经过认真验证。
{"title":"Simulation based education in paediatric resuscitation","authors":"","doi":"10.1016/j.prrv.2024.05.002","DOIUrl":"10.1016/j.prrv.2024.05.002","url":null,"abstract":"<div><p>There is increasing use of clinical Simulation Based Education (SBE) in healthcare due to an increased focus on patient safety, the call for a new training model not based solely on apprenticeship, a desire for standardised educational opportunities that are available on-demand, and a need to practice and hone skills in a controlled environment. SBE programs should be evaluated against Kirkpatrick level 3 or 4 criteria to ensure they improve patient or staff outcomes in the real world. SBE programs have been shown to improve outcomes in neonatology – reductions in hypoxic ischaemic encephalopathy, in brachial plexus injury, rates of school age cerebral palsy, reductions in 24hr mortality and improvements in first pass intubation rates. In paediatrics SBE programs have shown improvements in paediatric cardiac arrest survival, PICU survival, reduced PICU admissions, reduced PICU length of stay and reduced time to critical operations. SBE can improve the non-technical tasks of teamwork, leadership and communication (within the team and with patients and carers). Simulation is a useful tool in Quality and Safety and is used to identify latent safety issues that can be addressed by future programs. In high stakes assessment simulation can be a mode of assessment, however, care needs to be taken to ensure the tool is validated carefully.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000460/pdfft?md5=1205c6e575e72b7577f6230986913dcf&pid=1-s2.0-S1526054224000460-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating simulation teaching into acute clinical paediatrics 将模拟教学融入急诊儿科临床
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.05.003
{"title":"Integrating simulation teaching into acute clinical paediatrics","authors":"","doi":"10.1016/j.prrv.2024.05.003","DOIUrl":"10.1016/j.prrv.2024.05.003","url":null,"abstract":"","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141050345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders 神经肌肉障碍儿童咳嗽峰值流速与呼气峰值流速的比较
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.04.001

Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged < 20 years who performed spirometry and PCF testing on the same device (Vyaire Body BoxTM, Ultrasonic flow meter-based, or Vyaire PneumotachographTM, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.

在对患有神经肌肉障碍(NMD)的儿童进行呼吸评估时,通常会使用肺活量和咳嗽峰流速测试(PCF)。测试使用两种不同的机器,增加了实验室时间、成本和资源利用率。目前还没有研究对使用一种设备对 NMD 儿童进行肺活量测定和 PCF 所获得的呼气峰值流速 (PEF) 之间的相关性进行评估。2022-2024 年,Westmead 儿童医院对年龄小于 20 岁、使用同一设备(德国 Vyaire Body Box,超声波流量计;或 Vyaire Pneumotachograph,气动流量计)进行肺活量和 PCF 测试的 NMD 患儿进行了审核,以评估 PCF 和 PEF 之间的相关性。共确定了 51 组测试,40 名受试者(9F)的测试结果具有可重复性,并被纳入其中。年龄中位数(范围)为 14.95(7.20-19.00)岁。中位 PEF(L/min)为 4.05(1.22-10.26),中位 PCF(L/min)为 4.29(1.69-10.82)。PEF 和 PCF 具有很强的皮尔逊相关系数(R = 0.97,P = 0.03)。判定系数为 0.93。如果实验室资源允许,应将肺活量测定作为 NMD 患儿的首选检测方法。平均而言,肺活量测定需要多次操作才能达到 ATS/ERS 标准的重现性要求。对于无法进行技术上可接受的肺活量测定的儿童,可使用 PCF 测试。
{"title":"A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders","authors":"","doi":"10.1016/j.prrv.2024.04.001","DOIUrl":"10.1016/j.prrv.2024.04.001","url":null,"abstract":"<div><p><span><span>Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a </span>neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged &lt; 20 years who performed spirometry and PCF testing on the same device (Vyaire Body Box</span><sup>TM</sup>, Ultrasonic flow meter-based, or Vyaire Pneumotachograph<sup>TM</sup>, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140577331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care” "囊性纤维化中的抗生素超敏反应:彻底检查患者护理中的绊脚石"
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.01.004

One hurdle in the management of CF, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.

CF 是一种以进行性支气管内感染为特征的疾病,其治疗过程中的一个障碍是由于长期和重复的治疗过程而导致的对抗菌药物的超敏反应。本综述旨在汇编现有数据,并就这一长期争论的话题为医疗专业人员提供见解,以优化患者护理。本综述收集了过去 15 年中的临床研究,并根据其与药物超敏反应(DHR)、抗生素和 CF 的相关性进行了筛选。在完成筛选过程后,对 10 项临床研究进行了全面检查。与药物过敏反应相关的最常见抗生素组别是β-内酰胺类。各临床研究中最常见的总体反应类型(即刻反应或非即刻反应)的发生率各不相同。虽然严重的反应似乎比较罕见,但在治疗过程中甚至在治疗结束后确实会发生。真正的药物过敏发生率应使用现有的各种检测方法进行确认,但不应与总体 DHR 发生率相混淆。基因突变、性别和终生抗生素剂量与 DHR 发生风险的增加无关。相反,根据大多数研究,最重要的因素是特定时间内累积的抗菌剂剂量,尤其是经肠外给药时。DHR 是 CF 患者管理中一个无可争议的问题。在医院和门诊环境中,了解可能的风险因素并提高意识至关重要,因为早期发现可降低反应的严重程度。
{"title":"“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care”","authors":"","doi":"10.1016/j.prrv.2024.01.004","DOIUrl":"10.1016/j.prrv.2024.01.004","url":null,"abstract":"<div><p>One hurdle in the management of CF<span>, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity<span><span> reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic<span> group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. </span></span>Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.</span></span></p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139815878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to deliver effective paediatric simulation based education 如何有效开展儿科模拟教学
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.05.001

Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.

模拟教育(SBE)是一种教育工具,越来越多地被用于医疗保健专业人员的初始教育和继续教育。与所有教育工具一样,SBE 也需要合理使用才能达到预期效果。在模拟教学设计中使用认知负荷理论(CLT)对于通过减少外在负荷和优化内在负荷最大限度地提高参与者的学习效果至关重要。教育者可以修改任务保真度、任务复杂度和教学支持,以优化学习效果。在项目设计中可以使用特定的方法,如快速循环刻意练习、圆桌教学、低剂量高频率和翻转课堂。在选择设计元素时,保真度和真实性是需要考虑的重要因素,以确保学习者的参与度,但又不会加重认知负担。反馈或汇报是 SBE 不可分割的一部分。可以采用几种基于证据的方法来促进模拟后学习,包括 "良好判断汇报 "和 "PEARLS"。教育者还需要考虑教师的教育和发展,如发现、成长和成熟模型。
{"title":"How to deliver effective paediatric simulation based education","authors":"","doi":"10.1016/j.prrv.2024.05.001","DOIUrl":"10.1016/j.prrv.2024.05.001","url":null,"abstract":"<div><p>Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000459/pdfft?md5=383550ee0f562b49b2974a43484a2a11&pid=1-s2.0-S1526054224000459-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Paediatric Respiratory Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1